API 0.74% $1.35 australian pharmaceutical industries limited

Hi,A new rating for API from RBS, as upgrade to Buy. The broker...

  1. 61 Posts.
    Hi,

    A new rating for API from RBS, as upgrade to Buy. The broker notes a new Community Pharmacy Agreement is set to come into effect on July 1 next year, with the focus likely to be on an increase in the use of generics and improved transparency in mark-up pricing on drugs.

    Target price is $0.86! is this the explanation for all the action today?
 
watchlist Created with Sketch. Add API (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.